Abstract:Background
Temporomandibular disorders (TMDs) are common and cause persistent pain. Comorbidities are associated with TMDs and can affect the effectiveness of their treatments. The literature is lacking enough evidence on the difference between acute and chronic pain, particularly in TMDs. Investigating this difference could highlight potential risk factors for the transition from acute to chronic pain–related TMDs.
Aim
To compare the likelihood of back and neck pain (B… Show more
“…As clinical applicability to evidence-based practice, we suggest to the health professionals, first of all, screen fibromyalgia using specific instruments (e.g., the fibromyalgia rapid screening tool [ 41 ]). In the same way, other chronic musculoskeletal pain must be evaluated by specific instruments (respecting the cross-cultural adaptation [ 42 ]), because there are questionnaires, scales, and specific tests for low back pain [ 43 ], knee pain [ 44 ], neck pain [ 45 ], temporomandibular disorders [ 46 ], and other musculoskeletal diseases. Therefore, the WPI and SSS apply to the individuals which ACR has suggested: fibromyalgia patients [ 1 , 6 , 47 ].…”
Background
As with fibromyalgia, several musculoskeletal disorders are characterized by chronic pain, raising a clinical question – do the instruments used to assess fibromyalgia symptoms according to ACR criteria (ACR criteria) generate similar scores in other chronic musculoskeletal pain?
Objective
To compare the symptoms among fibromyalgia and other chronic musculoskeletal pain. Additionally, we also compared the most researched outcomes in fibromyalgia (i.e., present pain at rest and after movement; fatigue; pain severity and impact; function, global impact, and fibromyalgia symptom).
Methods
A cross-sectional study. Participants over 18 years old were included if they presented report of chronic musculoskeletal pain (≥ 3 months) and after that, they were divided into two groups (fibromyalgia and chronic pain). They answered the Fibromyalgia Impact Questionnaire-Revised (FIQ-R), Brief Pain Inventory (BPI), Numerical Pain Rating Scale (NPRS) for pain and fatigue, WPI, and SSS.
Results
A total of 166 participants were included in this study into two independent groups (chronic pain, n = 83; fibromyalgia, n = 83). We observed significant differences (p < 0.05) and large effect sizes (Cohen’s d, ≥ 0.7) in clinical outcomes comparisons between groups (i.e., widespread pain; symptom severity; present pain at rest and after movement; fatigue; pain severity and impact; function, global impact, and fibromyalgia symptoms).
Conclusion
Fibromyalgia patients (2016 ACR criteria) compared to other chronic musculoskeletal pain patients have higher levels of pain (at rest or after movement) and fatigue, greater impairment in both functionality and global impact, and worse symptoms. Therefore, the WPI and SSS instruments should be used exclusively to assess fibromyalgia symptoms.
“…As clinical applicability to evidence-based practice, we suggest to the health professionals, first of all, screen fibromyalgia using specific instruments (e.g., the fibromyalgia rapid screening tool [ 41 ]). In the same way, other chronic musculoskeletal pain must be evaluated by specific instruments (respecting the cross-cultural adaptation [ 42 ]), because there are questionnaires, scales, and specific tests for low back pain [ 43 ], knee pain [ 44 ], neck pain [ 45 ], temporomandibular disorders [ 46 ], and other musculoskeletal diseases. Therefore, the WPI and SSS apply to the individuals which ACR has suggested: fibromyalgia patients [ 1 , 6 , 47 ].…”
Background
As with fibromyalgia, several musculoskeletal disorders are characterized by chronic pain, raising a clinical question – do the instruments used to assess fibromyalgia symptoms according to ACR criteria (ACR criteria) generate similar scores in other chronic musculoskeletal pain?
Objective
To compare the symptoms among fibromyalgia and other chronic musculoskeletal pain. Additionally, we also compared the most researched outcomes in fibromyalgia (i.e., present pain at rest and after movement; fatigue; pain severity and impact; function, global impact, and fibromyalgia symptom).
Methods
A cross-sectional study. Participants over 18 years old were included if they presented report of chronic musculoskeletal pain (≥ 3 months) and after that, they were divided into two groups (fibromyalgia and chronic pain). They answered the Fibromyalgia Impact Questionnaire-Revised (FIQ-R), Brief Pain Inventory (BPI), Numerical Pain Rating Scale (NPRS) for pain and fatigue, WPI, and SSS.
Results
A total of 166 participants were included in this study into two independent groups (chronic pain, n = 83; fibromyalgia, n = 83). We observed significant differences (p < 0.05) and large effect sizes (Cohen’s d, ≥ 0.7) in clinical outcomes comparisons between groups (i.e., widespread pain; symptom severity; present pain at rest and after movement; fatigue; pain severity and impact; function, global impact, and fibromyalgia symptoms).
Conclusion
Fibromyalgia patients (2016 ACR criteria) compared to other chronic musculoskeletal pain patients have higher levels of pain (at rest or after movement) and fatigue, greater impairment in both functionality and global impact, and worse symptoms. Therefore, the WPI and SSS instruments should be used exclusively to assess fibromyalgia symptoms.
“…Also, patients with high grade of disability at baseline had an increased risk of developing chronic TMD, even if this risk did not reach significance ( 33 ). Finally, another study found that chronic neck pain was more prevalent in patients with chronic TMD pain and disability than acute TMD pain, suggesting that chronic disability might be involved in the transition from acute to chronic TMD pain ( 39 ). However, the factors involved in the transition from acute to chronic pain are almost unknown and much more research is needed to understand this in order to be able to prevent the transition.…”
Section: The Transition From Acute To Chronic Tmd Painmentioning
Mastication myalgia is the most common cause of non-odontogenic pain in the orofacial region and is often associated with a reduced quality of life. The purpose of this review is to provide an overview of the clinical aspects of myalgia based on available research. The review includes epidemiological, diagnostic, and etiological aspects. In addition, the potential risk factors related to the transition from acute to chronic myalgia are explored and treatment strategies are presented for its management. As a result, this review may increase clinical knowledge about mastication myalgia and clarify strategies regarding prevention, diagnostics, and management to improve prognosis and reduce patient suffering.
“…Painful orofacial and neck comorbidities are often associated with the TMD [ 63 ]. These coexisting conditions (particularly, headache, migraine, and neck pain) are not only highly associated with chronic pain-related TMDs but also increase the risk of their development [ 38 , 64 , 65 ]. The International Classification of Headache Disorders (ICHD) [ 66 ] and the DC/TMD [ 1 ] consider the main characteristics of pain in headaches and TMD, respectively.…”
Section: Diagnosis Of Central Sensitization In Tmdmentioning
confidence: 99%
“…There are several hypotheses attempting to explain the association between TMD and headaches, including neuronal convergence, central sensitization, and inhibition of the descending pain downregulation mechanisms [ 67 , 68 ]. The strict relationship between TMD, headaches, and neck pain has been recently evaluated, not only in terms of sharing common pathogenic mechanisms and clinical features but also considering that one condition might influence or promote the development of another [ 11 , 64 , 69 ]. These conditions can cause facial pain and are frequently associated with the development of craniofacial allodynia during painful exacerbation [ 12 ].…”
Section: Diagnosis Of Central Sensitization In Tmdmentioning
Temporomandibular disorders (TMD) are a group of musculoskeletal diseases affecting masticatory muscles and temporomandibular joints (TMJ). In this context, the chronic TMD could be considered as a condition with chronic primary orofacial pain, presenting as myofascial TMD pain or TMJ arthralgia. In this context, myogenous TMD may present overlapping features with other disorders, such as fibromyalgia and primary headaches, characterized by chronic primary pain related to dysfunction of the central nervous system (CNS), probably through the central sensitization. This phenomenon could be defined as an amplified response of the CNS to sensory stimuli and peripheral nociceptive, characterized by hyperexcitability in the dorsal horn neurons in the spinal cord, which ascend through the spinothalamic tract. The main objectives of the management of TMD patients are: decreasing pain, increasing TMJ function, and reducing the reflex masticatory muscle spasm/pain. The first-line treatments are physical therapy, pharmacological drugs, occlusal splints, laser therapy, extracorporeal shockwave therapy, transcutaneous electrical nerve stimulation, and oxygen–ozone therapy. Although all these therapeutic approaches were shown to have a positive impact on the central sensitization of TMD pain, there is still no agreement on this topic in the scientific literature. Thus, in this comprehensive review, we aimed at evaluating the evidence on pain management and rehabilitation for the central sensitization in TMD patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.